Innovation with Intention: Upcoming Retinal Disease Therapies on Spotlight at APVRS 2025
From gene therapy to biosimilars and sustained delivery, experts weigh in what truly moves the needle for patients. On the…
Faricimab – The Fight Against Retinal Diseases
Faricimab (Vabysmo) is the first approved bispecific antibody uniquely engineered to block two key pathways driving retinal vascular disease by…
latest posts
